NMIN names new Scientific Director & CEO Dr. Christine Allen

The NanoMedicines Innovation Network (NMIN), a national research network funded by the Government of Canada, has appointed Dr. Christine Allen Scientific Director & CEO, effective 1 July 2021.
VANCOUVER, BC (18 June 2021)


Canadian technology enables Pfizer’s promising COVID-19 vaccine

Pfizer has caught the world’s attention with its promising early results for a COVID-19 vaccine candidate. What has been less widely publicized is the pivotal role of Canadian know-how and technology in the development of this potential vaccine.

VANCOUVER, BC (12 November 2020)


Gene therapy enabled by nanotechnology: A new era of medicine

NanoMedicines Innovation Network (NMIN) thought leaders contribute to a commentary in the December 2019 issue of Nature Nanotechnology

VANCOUVER, BC (4 December 2019)